These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3468284

  • 21. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
    Zhou X, Lu X, Arthur G.
    Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
    [Abstract] [Full Text] [Related]

  • 22. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
    Samadder P, Arthur G.
    Cancer Res; 1999 Oct 01; 59(19):4808-15. PubMed ID: 10519389
    [Abstract] [Full Text] [Related]

  • 23. Antiinvasive activity of hexadecylphosphocholine in vitro.
    Schallier DC, Bruyneel EA, Storme GA, Hilgard P, Mareel MM.
    Anticancer Res; 1991 Oct 01; 11(3):1285-92. PubMed ID: 1888162
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of cell division but not nuclear division by 1-O- octadecyl-2-O-methyl-Sn-glycero-3-phosphocholine.
    Pushkareva MY, Janoff AS, Mayhew E.
    Cell Biol Int; 1999 Oct 01; 23(12):817-28. PubMed ID: 10772756
    [Abstract] [Full Text] [Related]

  • 25. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
    Danhauser-Riedl S, Himmelmann A, Steinhauser G, Busch R, Vogler WR, Rastetter J, Berdel WE.
    J Lipid Mediat; 1990 Oct 01; 2(5):271-80. PubMed ID: 2133272
    [Abstract] [Full Text] [Related]

  • 26. Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid.
    Helfman DM, Barnes KC, Kinkade JM, Vogler WR, Shoji M, Kuo JF.
    Cancer Res; 1983 Jun 01; 43(6):2955-61. PubMed ID: 6850605
    [Abstract] [Full Text] [Related]

  • 27. Differentiation of HL-60 cells distinguishes between cytostatic and cytotoxic effects of the alkylphospholipid ET-18-OCH3.
    Civoli F, Pauig SB, Daniel LW.
    Cancer Chemother Pharmacol; 1996 Jun 01; 38(3):269-72. PubMed ID: 8646802
    [Abstract] [Full Text] [Related]

  • 28. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Ahmad I, Filep JJ, Franklin JC, Janoff AS, Masters GR, Pattassery J, Peters A, Schupsky JJ, Zha Y, Mayhew E.
    Cancer Res; 1997 May 15; 57(10):1915-21. PubMed ID: 9157985
    [Abstract] [Full Text] [Related]

  • 29. Sensitivity of human hematopoietic cell lines to an alkyl-lysophospholipid-derivative.
    Roos G, Berdel WE.
    Leuk Res; 1986 May 15; 10(2):195-202. PubMed ID: 3951252
    [Abstract] [Full Text] [Related]

  • 30. Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells.
    Kosano H, Takatani O.
    J Lipid Mediat; 1990 May 15; 2(2):117-21. PubMed ID: 2135668
    [Abstract] [Full Text] [Related]

  • 31. Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells.
    Botzler C, Kolb HJ, Issels RD, Multhoff G.
    Int J Cancer; 1996 Mar 01; 65(5):633-8. PubMed ID: 8598315
    [Abstract] [Full Text] [Related]

  • 32. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine.
    Boggs KP, Rock CO, Jackowski S.
    J Biol Chem; 1995 May 12; 270(19):11612-8. PubMed ID: 7744800
    [Abstract] [Full Text] [Related]

  • 33. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
    Wilcox RW, Wykle RL, Schmitt JD, Daniel LW.
    Lipids; 1987 Nov 12; 22(11):800-7. PubMed ID: 3444369
    [Abstract] [Full Text] [Related]

  • 34. Increased generation of lipid-derived and ascorbate free radicals by L1210 cells exposed to the ether lipid edelfosine.
    Wagner BA, Buettner GR, Burns CP.
    Cancer Res; 1993 Feb 15; 53(4):711-3. PubMed ID: 8428351
    [Abstract] [Full Text] [Related]

  • 35. ET-18-OCH3 inhibits the phosphorylation and activation of p70 S6 kinase in MCF-7 cells.
    Arthur G, Samadder P, Bittman R.
    Anticancer Res; 2005 Feb 15; 25(1A):95-100. PubMed ID: 15816524
    [Abstract] [Full Text] [Related]

  • 36. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F, Fernández-Luna JL, Gajate C, Martín-Martín B, Benito A, Martínez-Dalmau R, Modolell M.
    Cancer Res; 1997 Apr 01; 57(7):1320-8. PubMed ID: 9102220
    [Abstract] [Full Text] [Related]

  • 37. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
    Schick HD, Berdel WE, Fromm M, Fink U, Jehn U, Ulm K, Reichert A, Eibl H, Unger C, Rastetter J.
    Lipids; 1987 Nov 01; 22(11):904-10. PubMed ID: 3444383
    [Abstract] [Full Text] [Related]

  • 38. Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3.
    Heesbeen EC, Rijksen G, van Heugten HG, Verdonck LF.
    Leuk Res; 1995 Jun 01; 19(6):417-25. PubMed ID: 7596155
    [Abstract] [Full Text] [Related]

  • 39. Cell kill and cytostasis by ET-18-OCH3 and heat.
    Fujiwara K, Modest EJ, Wallen CA.
    Anticancer Res; 1995 Jun 01; 15(4):1333-8. PubMed ID: 7654017
    [Abstract] [Full Text] [Related]

  • 40. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
    Samadder P, Richards C, Bittman R, Bhullar RP, Arthur G.
    Anticancer Res; 2003 Jun 01; 23(3B):2291-5. PubMed ID: 12894505
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.